<DOC>
	<DOCNO>NCT00831662</DOCNO>
	<brief_summary>The purpose study confirm safety efficacy diquafosol tetrasodium ophthalmic solution , 2 % vs. placebo , subject dry eye disease .</brief_summary>
	<brief_title>The Effects Diquafosol Tetrasodium Ophthalmic Solution , 2 % Subjects With Dry Eye Disease ( P08637 )</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Have best correct visual acuity eye least +0.7 good Central corneal stain 3 NEI scale If female , nonpregnant nonlactating Have history dry eye disease eye Have normal lid anatomy Unable withhold use contact lenses study 2 week prior study Have ocular surface surgery within past year Are consider legally blind one eye Have serious medical condition could confound study assessment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>